3,3',4',5,5'-Pentahydroxyflavone is a potent inhibitor of amyloid β fibril formation

Neuroscience Letters

Volumn 513, Issue 1, 2012, Pages 51-56

  Ushikubo, Hiroko ^a   Watanabe, Sayaka ^a   Tanimoto, Yui ^a   Abe, Kazuho ^a   Hiza, Aiki ^b   Ogawa, Takahiro ^b   Asakawa, Tomohiro ^b   Kan, Toshiyuki ^b   Akaishi, Tatsuhiro ^a  

^a MUSASHINO UNIVERSITY   (Japan)

^b UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

3,3',4',5,5' Pentahydroxyflavone; Alzheimer's disease; Amyloid protein; Fisetin; Flavonoids

Indexed keywords

3',4',7 TRIHYDROXYFLAVONE; 3,3',4',5,5' PENTAHYDROXYFLAVONE; 3,4' DIHYDROXYFLAVONE; 4' HYDROXYFLAVONE; AMYLOID BETA PROTEIN; FISETIN; FLAVONE DERIVATIVE; MYRICETIN; TETRAHYDROXYFLAVONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG SYNTHESIS; FLUORESCENCE ANALYSIS; HIPPOCAMPUS; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT; STRUCTURE ACTIVITY RELATION;

AMYLOID BETA-PEPTIDES; ANIMALS; CELLS, CULTURED; FLAVONOIDS; HIPPOCAMPUS; HUMANS; HYDROXYLATION; NEUROFIBRILLARY TANGLES; PEPTIDE FRAGMENTS; RATS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84858159199     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.02.006     Document Type: Article

References (20)

1. Abe K., Takayanagi M., Saito H. Effects of recombinant human basic fibroblast growth factor and its modified protein CS23 on survival of primary cultured neurons from various regions of fetal rat brain. Jpn. J. Pharmacol. 1990, 53:221-227.
2. Akaishi T., Morimoto T., Shibao M., Watanabe S., Sakai-Kato K., Utsunomiya-Tate N., Abe K. Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein. Neurosci. Lett. 2008, 444:280-285.
3. Arai Y., Watanabe S., Kimira M., Shimoi K., Mochizuki R., Kinae N. Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J. Nutr. 2000, 130:2243-2250.
4. Asakawa T., Hiza A., Nakayama M., Inai M., Oyama D., Koide H., Shimizu K., Wakimoto T., Harada N., Tsukada H., Oku N., Kan T. PET imaging of nobiletin based on a practical total synthesis. Chem. Commun. 2011, 47:2868-2870.
5. Cao A., Hu D., Lai L. Formation of amyloid fibrils from fully reduced hen egg white lysozyme. Protein Sci. 2004, 13:319-324.
6. Furuta T., Nakayama M., Suzuki H., Tajimi H., Inai M., Nukaya H., Wakimoto T., Kan T. Concise synthesis of chafurosides A and B. Org. Lett. 2009, 11:2233-2236.
7. Hirohata M., Hasegawa K., Tsutsumi-Yasuhara S., Ohhashi Y., Ookoshi T., Ono K., Yamada M., Naiki H. The anti-amyloidogenic effect is exerted against Alzheimer's beta-amyloid fibrils in vitro by preferential and reversible binding of flavonoids to the amyloid fibril structure. Biochemistry 2007, 46:1888-1899.
8. Ishige K., Schubert D., Sagara Y. Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radical Biol. Med. 2001, 30:433-446.
9. Kim H., Park B.-S., Lee K.-G., Choi C.Y., Jang S.S., Kim Y.-H., Lee S.-E. Effects of naturally occurring compounds on fibril formation and oxidative stress of β-amyloid. J. Agric. Food Chem. 2005, 53:8537-8541.
10. Lozenzo A., Yankner B.A. β-Amyloid neurotoxicity requires fibril formation and is inhibited by Congo red. Proc. Natl. Acad. Sci. U. S. A. 1994, 91:12243-12247.
11. Maher P., Akaishi T., Abe K. Flavonoid fisetin promotes ERK-dependent long-term potentiation and enhances memory. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:16568-16573.
12. Martin J.B. Molecular basis of the neurodegenerative disorders. N. Eng. J. Med. 1999, 340:1970-1981.
13. May P.C., Gitter B.D., Waters D.C., Simmons L.K., Becker G.W., Small J.S.P.M. Robison, beta-Amyloid peptide in vitro toxicity: lot-to-lot variability. Neurobiol. Aging 1992, 13:605-607.
14. McLaurin J., Kierstead M.E., Brown M.E., Hawkes C.A., Lambermon M.H.L., Phinney A.L., Darabie A.A., Cousins J.E., French J.E., Lan M.F., Chen F., Wong S.S.N., Mount H.T.J., Fraser P.E., Westaway D., St.George-Hyslop P. Cyclohexanehexol inhibitors of Aβ aggregation prevent and reverse Alzheimer. Nat. Med. 2006, 12:801-808.
15. Ono K., Yoshiike Y., Takashima A., Hasegawa K., Naiki H., Yamada M. Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease. J. Neurochem. 2003, 87:172-181.
16. Rivière C., Richard T., Vitrac X., Mérillon J.M., Valls J., Monti J.P. New polyphenols active on beta-amyloid aggregation. Bioorg. Med. Chem. Lett. 2008, 18:828-831.
17. Sagara Y., Vanhnasy J., Maher P. Induction of PC12 cell differentiation by flavonoids is dependent upon extracellular signal-regulated kinase activation. J. Neurochem. 2004, 90:1144-1155.
18. Soto C., Sigurdsson E.M., Morelli L., Kumar R.A., Castaño E.M., Frangione B. β-Sheet breaker peptide inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat. Med. 1998, 4:822-826.
19. Yang F., Lim G.P., Begun A.N., Ubeda O.J., Simmons M.R., Ambegaokar S.S., Chen P., Kayed R., Glabe C.G., Frautschy S.A., Cole G.M. Curcumin inhibits formation of amyloid β oligomers and fibrils binds plaque, and reduces amyloid in vivo. J. Biol. Chem. 2005, 280:5892-5901.
20. Yoshida A., Hirooka Y., Sugata Y., Nitta M., Manabe T., Ido S., Murakami K., Saha R.K., Suzuki T., Ohshima M., Yoshida A., Itoh K., Shimizu K., Oku N., Furuta T., Asakawa T., Wakimoto T., Kan T. Concise synthesis of catechin probes enabling analysis and imaging of EGCg. Chem. Commun. 2011, 47:1794-1796.